Medicenna Therapeutics is a clinical-stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). Their mission is to become the leader in the development and commercialization of targeted ECs and Superkines f... Read more
Zenas BioPharma
7 followers
Vaxcyte
5 followers
Enable Medicine
5 followers
Discovery Life Sciences
3 followers
Tango Therapeutics
3 followers
Mineralys Therapeutics
3 followers
nplex biosciences
1 follower
Forge Biologics
2 followers
Apogee Therapeutics
2 followers
Isotopen Technologien München
1 follower
Entos
1 follower
Odyssey Therapeutics
4 followers